Institute of Psychology, University of Economics and Human Sciences in Warsaw, Okopowa 59, 01-030 Warsaw, Poland; Faculty of Psychology, University of Warsaw, Stawki 5/7, 00-183 Warsaw, Poland.
Institute of Psychology, University of Economics and Human Sciences in Warsaw, Okopowa 59, 01-030 Warsaw, Poland; Faculty of Psychology, University of Warsaw, Stawki 5/7, 00-183 Warsaw, Poland.
Joint Bone Spine. 2022 May;89(3):105298. doi: 10.1016/j.jbspin.2021.105298. Epub 2021 Oct 14.
An increasing number of studies have demonstrated cognitive impairment in patients with rheumatoid arthritis (RA). The literature indicates many factors play an important role in this clinical problem, such as the severity of depressive symptoms and the treatment used. The aim of this study was to systematically review studies comparing cognitive functioning between healthy participants and RA patients and to determine both the severity and potential moderators of cognitive impairment.
For this purpose, 16 studies that fulfilled all selection criteria were carefully selected. Altogether, 921 patients with RA (812 women and 109 men) and 700 controls participated in these studies. Due to the inability to perform a network meta-analysis, it was decided to determine the effect sizes for studies which used the same measurement methods.
The analysis demonstrated greater impairment of cognitive functioning in patients with RA than in healthy controls, with effect sizes ranging from small to large, depending on the assessment method used in the study.
The study pinpoints potential biases, lack of replication, and inconsistencies in reporting data as possible confounding factors and suggests further recommendations for assessment methods, research directions and clinical implications.
Not applicable.
越来越多的研究表明类风湿关节炎(RA)患者存在认知障碍。文献表明,许多因素在这一临床问题中起着重要作用,如抑郁症状的严重程度和所采用的治疗方法。本研究旨在系统地回顾比较健康参与者和 RA 患者认知功能的研究,并确定认知障碍的严重程度和潜在的调节因素。
为此,仔细选择了符合所有选择标准的 16 项研究。共有 921 名 RA 患者(812 名女性和 109 名男性)和 700 名对照者参与了这些研究。由于无法进行网络荟萃分析,因此决定确定使用相同测量方法的研究的效应量。
分析表明,RA 患者的认知功能障碍程度大于健康对照组,其效应量大小不一,具体取决于研究中使用的评估方法。
该研究指出了潜在的偏倚、缺乏复制和数据报告的不一致性,这些可能是混杂因素,并提出了进一步的评估方法、研究方向和临床意义的建议。
不适用。